# Filing Detail

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001140361-22-024668
Filing Date
2022-07-01
Accepted
2022-06-30 21:28:10
Documents
94
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K/A | brhc10039222_10ka.htm iXBRL | 10-K/A | 2249555
2 | EXHIBIT 23.1 | brhc10039222_ex23-1.htm | EX-23.1 | 4159
3 | EXHIBIT 31.1 | brhc10039222_ex31-1.htm | EX-31.1 | 9752
4 | EXHIBIT 31.2 | brhc10039222_ex31-2.htm | EX-31.2 | 9961
5 | EXHIBIT 32.1 | brhc10039222_ex32-1.htm | EX-32.2 | 3698
6 | EXHIBIT 32.2 | brhc10039222_ex32-2.htm | EX-32.2 | 3595
| Complete submission text file | 0001140361-22-024668.txt |  | 11951895

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA | btx-20211231.xsd | EX-101.SCH | 88504
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | btx-20211231_cal.xml | EX-101.CAL | 84895
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | btx-20211231_def.xml | EX-101.DEF | 418071
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | btx-20211231_lab.xml | EX-101.LAB | 1120511
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | btx-20211231_pre.xml | EX-101.PRE | 655268
88 | EXTRACTED XBRL INSTANCE DOCUMENT | brhc10039222_10ka_htm.xml | XML | 2249599

Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-11460 | Film No.: 221059371
SIC: 2834 Pharmaceutical Preparations